Skip to content

Wall Street sets Palantir stock price for the next 12 months

Wall Street sets Palantir stock price for the next 12 months
Ana Zirojevic

With the big data analytics software company Palantir Technologies (NYSE: PLTR) going through a rough time these past weeks amid concerns over its upcoming contract renewal with the United States Army, experts are on the fence regarding the price of its stock in the next 12 months.

As a reminder, Palantir is waiting to sign a renewal contract with the US Army, as its previous four-year deal expires in two weeks. However, a William Blair analyst, Louie DiPalma, opined that its new agreement could be significantly less than the original $458 million, as he explained in a note on December 4.

Wall Street weighs in on PLTR stock

In addition to DiPalma’s concerns, a group of 15 Wall Street analysts is largely undecided on the price of Palantir for the next 12 months, rating it as a ‘Hold’ for now on the basis of five votes, while five declared it a ‘Buy’ and another five advised ‘Sell,’ as per the latest TipRanks data on December 8.

PLTR 12-month price forecast. Source: TipRanks

On top of that, they have provided 12-month price targets over the course of the last three months, which averaged $14.67, suggesting a decline of nearly 14.81% from its current price, whereas the minimum prediction is $5.00 (-70.97%), and the maximum forecast stands at $25.00 (+45.18%).

Palantir stock price analysis 

Presently, the price of PLTR stands at $17.22, demonstrating a modest gain of 0.53% on the day but also a decline of 15% across the previous week, as well as a loss of 14% on its monthly chart, according to the most recent information retrieved by Finbold on December 8.

Palantir 30-day stock price chart. Source: ChartMill

Indeed, the price of Palantir has been in a strong decline lately, trading in the very wide range between $17.05 and $21.85 in the last month and near the lows of this range at press time, doing well in the medium-term but demonstrating a negative trend in the short term.

On the other hand, it is trading in the upper part of its 52-week range and remains one of the better performers in the overall market, doing better than 97% of all other stocks in its yearly performance, as well as outperforming 91% of the 282 stocks in the software industry.

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.